Non-fullerene acceptors have recently attracted tremendous interest because of their potential as alternatives to fullerene derivatives in bulk heterojunction organic solar cells. However, the power conversion efficiencies (PCEs) have lagged far behind those of the polymer/fullerene system, mainly because of the low fill factor (FF) and photocurrent. Here we report a novel perylene bisimide (PBI) acceptor, SdiPBI-Se, in which selenium atoms were introduced into the perylene core. With a well-established wide-band-gap polymer (PDBT-T1) as the donor, a high efficiency of 8.4% with an unprecedented high FF of 70.2% is achieved for solution-processed non-fullerene organic solar cells. Efficient photon absorption, high and balanced charge carrier mobility, and ultrafast charge generation processes in PDBT-T1:SdiPBI-Se films account for the high photovoltaic performance. Our results suggest that non-fullerene acceptors have enormous potential to rival or even surpass the performance of their fullerene counterparts.
A novel wide‐bandgap copolymer (PDBT‐T1) is developed and applied in organic solar cells, which yield a high efficiency of 9.74% and a high fill factor of 75%. The high photovoltaic performance is due to efficient photogenerated exciton dissociation and charge collection in PDBT‐T1‐based solar cells. The results show that PDBT‐T1 is an outstanding candidate as a wide‐bandgap material for tandem (or multi‐junction) organic solar cells.
A fullerene additive adjusts the miscibility between donor and acceptor for morphology optimization and reduces bimolecular recombination, assisting significant improvement of fill factor and efficiency.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.